{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:57:16Z","timestamp":1793145436932,"version":"4.5.0"},"reference-count":30,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can J Psychiatry"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Stimulant drug treatment in preschool-age children for attention-deficit hyperactivity disorder (ADHD) as well as the concomitant use of antipsychotic drugs is largely unstudied in terms of longitudinal outcomes. We characterized longitudinal patterns of stimulant drug use in children diagnosed for ADHD and analyzed the mental health disorders leading to add-on therapy with antipsychotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      The study population comprised of children and adolescents (age: 0\u201319 years) in the province of British Columbia (BC), Canada, with at least one dispensing for any psychotropic drug between 1997 and 2017 (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009144,825). BC health administrative databases were used to identify children with diagnosis for ADHD and dispensings for stimulant and antipsychotic drugs. Longitudinal patterns of drug use and diagnostic codes proximal to the add-on of antipsychotics were assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>We found that residence in rural regions and lack of child psychiatrists are significantly associated with higher rates of stimulant drug prescription in preschool and early school-age children. Residence in rural regions was also associated with a higher rate for the concomitant use of antipsychotics over the course of stimulant treatment. When comparing children starting stimulant therapy before the age of 6 with those starting therapy after 6 years,<\/jats:italic>\n                      we found an 82% increase in the likelihood of antipsychotic add-on in those starting stimulants at younger ages (HR: 1.82, 95% CI [1.63\u20132.04]). Moreover, children starting stimulant therapy before the age of 6 years had 3.57-fold higher rates of diagnostic codes for specific delays in development (ICD-9 315) in close proximity to the antipsychotic add-on.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The question remains whether the add-on of antipsychotics is a consequence of insufficient action of the stimulant in ADHD, or required to ameliorate the adverse effects of the stimulant drug. Our result suggests that care need to be taken in the diagnosis for ADHD in children at the age when entering elementary school.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Plain Language Title<\/jats:title>\n                    <jats:p>Antipsychotic use in children previously diagnosed for ADHD and treated with stimulant medication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/07067437241309679","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T10:16:23Z","timestamp":1737108983000},"page":"382-391","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Antipsychotic Drug Prescribing in Children Previously Treated With Stimulants for ADHD: A Population-Based Longitudinal Study: La prescription d'antipsychotiques chez les enfants pr\u00e9c\u00e9demment trait\u00e9s avec des stimulants pour le TDAH : une \u00e9tude longitudinale bas\u00e9e sur la population"],"prefix":"10.1177","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0782-4833","authenticated-orcid":false,"given":"Hans J.","family":"Gober","sequence":"first","affiliation":[{"name":"Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada"},{"name":"Department of Pharmacy, Kepler University Hospital, Neuromed Campus, Johannes Kepler University, Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy H.","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada"},{"name":"Therapeutic Evaluation Unit, Provincial Health Services Authority, Vancouver, Canada"},{"name":"BC Children's Hospital Research Institute, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce C.","family":"Carleton","sequence":"additional","affiliation":[{"name":"Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada"},{"name":"Therapeutic Evaluation Unit, Provincial Health Services Authority, Vancouver, Canada"},{"name":"BC Children's Hospital Research Institute, Vancouver, Canada"},{"name":"Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.03.002"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101780"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0070-0"},{"key":"e_1_3_3_5_2","unstructured":"National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline [NG87]. Last updated: 13 September 2019. Available at: www.nice.org.uk\/guidance\/ng87. 2018."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1308"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/13634593221093492"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0026582"},{"issue":"6","key":"e_1_3_3_9_2","first-page":"889","article-title":"Relative age effect in attention deficit\/hyperactivity disorder at various stages of the medicalization process","volume":"9","author":"Brault MC","year":"2022","unstructured":"Brault MC, Degroote E, Jean M, et al. Relative age effect in attention deficit\/hyperactivity disorder at various stages of the medicalization process. Children (Basel). 2022;9(6):889.","journal-title":"Children (Basel)"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00042-1"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/1087054718784668"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300391"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2018.0024"},{"issue":"8","key":"e_1_3_3_14_2","article-title":"Atypical antipsychotics for disruptive behaviour disorders in children and youths","volume":"8","author":"Loy JH","year":"2017","unstructured":"Loy JH, Merry SN, Hetrick SE, et al. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database Syst Rev. 2017;8(8):CD008559. DOI: https:\/\/doi.org\/10.1002\/14651858.CD008559.pub3","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540260801889179"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/0706743718779950"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180355"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2016.03.014"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0005"},{"key":"e_1_3_3_20_2","unstructured":"British Columbia Ministry of Health. Medical Services Plan (MSP) Payment Information File. British Columbia Ministry of Health. Data Extract. MOH. www2.gov.bc.ca\/gov\/content\/health\/conducting-health-research-evaluation\/data-access-health-data-central. 2019."},{"key":"e_1_3_3_21_2","unstructured":"Canadian Institute of Health Information. Discharge Abstract Database (Hospital Separations). British Columbia Ministry of Health. Data Extract. MOH. www2.gov.bc.ca\/gov\/content\/health\/conducting-health-research-evaluation\/data-access-health-data-central. 2019."},{"key":"e_1_3_3_22_2","unstructured":"British Columbia Ministry of Health. PharmaNet Data and Consolidation File (MSP Registration and Premium Billing). British Columbia Ministry of Health. Data Extract. MOH. www2.gov.bc.ca\/gov\/content\/health\/conducting-health-research-evaluation\/data-access-health-data-central. 2019."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-012-9214-1"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2014.05.010"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.04.001"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0051"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m14331"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-04356-w"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02821-x"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-004-2848-1"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30269-4"}],"container-title":["The Canadian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/07067437241309679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/07067437241309679","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/07067437241309679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:15:54Z","timestamp":1777392954000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/07067437241309679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/07067437241309679"],"URL":"https:\/\/doi.org\/10.1177\/07067437241309679","relation":{},"ISSN":["0706-7437","1497-0015"],"issn-type":[{"value":"0706-7437","type":"print"},{"value":"1497-0015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}